FindTrial
Sign In

Effect of oxycodone-esmketamine PCIA combined with anterior serratus plane block on postoperative analgesia in patients with thoracoscopic lung cancer

Effect of oxycodone-esmketamine PCIA combined with anterior serratus plane block on postoperative analgesia in patients with thoracoscopic lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052611
Enrollment
Unknown
Registered
2021-11-02
Start date
2021-11-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Experimental group1:oxycodone PCIA
Control group:Sufentanil
Experimental group2:oxycodone-esmketamine

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 45 to 70 years; 2.ASA I to III.

Exclusion criteria

Exclusion criteria: 1. Chronic renal failure (glomerular filtration rate 30 kg/m–2); 7. Hypersensitivity to the drugs used in the study.

Design outcomes

Primary

MeasureTime frame
Consumption of analgesics 72 hours after operation;—

Secondary

MeasureTime frame
Pain intensity;Level of Sedation;Bruggrmann comfort scale;Consumption of anesthetic drug and Vasoactive drugs;—

Countries

China

Contacts

Public ContactXu Qing

Liaocheng People's Hospital

xq0406a@163.com+86 18353576517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026